FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/107822 [Registered on: 07/04/2026] Trial Registered Prospectively
Last Modified On: 20/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Diagnostic
Screening
Dentistry 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   A study to see whether treating severe gum disease can help lower blood pressure, reduce inflammation, and improve cholesterol levels in people who already have high blood pressure 
Scientific Title of Study   EFFECT OF PERIODONTAL THERAPY ON BLOOD PRESSURE LEVELS,SERUM C-REACTIVE PROTEIN AND LIPID PROFILE IN HYPERTENSIVE PATIENTS WITH STAGE III PERIODONTITIS-A CLINICO HEMATOLOGICAL STUDY 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSwathi S Malagatti 
Designation  post graduate student 
Affiliation  COORG INSTITUTE OF DENTAL SCIENCES 
Address  Coorg institute of dental sciences ,department of Periodontics and Implantology,room no 4 ,KK campus,Maggula village,Virajpet,District-Kodagu

Kodagu
KARNATAKA
571218
India 
Phone  9108057410  
Fax    
Email  swathimalagatti@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Walvekar 
Designation  HOD 
Affiliation  COORG INSTITUTE OF DENTAL SCIENCES 
Address  Coorg institute of dental sciences ,Department of Periodontics and Implantology,Room no 4,K K campus ,Maggula village,Virajpet-571218,Karnataka,Kodagu,India

Kodagu
KARNATAKA
571218
India 
Phone  9480085687  
Fax    
Email  amitakw@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  DrSwathi S Malagatti 
Designation  post graduate student 
Affiliation  COORG INSTITUTE OF DENTAL SCIENCES 
Address  Coorg institute of dental sciences ,Department of Periodontics and Implantology,room no 4,K K campus ,Maggula village,Virajpet-571218,Karnataka,Kodagu,India

Kodagu
KARNATAKA
571218
India 
Phone  9108057410  
Fax    
Email  swathimalagatti@gmail.com  
 
Source of Monetary or Material Support  
COORG INSTITUTE OF DENTAL SCIENCES,DEPARTMENT OF PERIODONTICS AND IMPLANTOLOGY,KANJITHANDA KUSHALAPPA CAMPUS,MAGGULA VILLAGE,VIRAJPET-571218,KODAGU,KARNATAKA 
 
Primary Sponsor  
Name  Dr SWATHI S MALAGATTI 
Address  COORG INSTITUTE OF DENTAL SCIENCES,DEPARTMENT OF PERIODONTICS AND IMPLANTOLOGY,KANJITHANDA KUSHALAPPA CAMPUS,MAGGULA VILLAGE,VIRAJPET-571218,KODAGU,KARNATAKA 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSwathi S Malagatti  Coorg institute of dental sciences  Coorg institute of dental sciences ,Department of Periodontics and implantology,Room no 4,K K campus ,Maggula village,Virajpet-571218,Karnataka,Kodagu,India
Kodagu
KARNATAKA 
09108057410

swathimalagatti@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL REVIEW BOARD,COORG INSTITUTE OF DENTAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  not applicable  not applicable 
Intervention  scaling and root planing followed by flap surgery  Scaling and root planing will be performed to eliminate subgingival plaque and calculus, thereby reducing periodontal inflammation. Patients with residual pockets will subsequently undergo periodontal flap surgery to achieve further pocket reduction and improve periodontal health 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1) Patients of age more than 18 years
2) Patients with known hypertension
3) Patients with stage III Periodontitis (probing depth greater than or equal to 6mm)
4) Patients with radiographic evidence of bone loss
 
 
ExclusionCriteria 
Details  (1) active infectious diseases, such as hepatitis, HIV, or tuberculosis,
(2) pregnant or breastfeeding, and
(3) taking nonsteroidal anti-inflammatory drugs on a regular basis or taking antibiotics within 3 months of assessment.
(4) Smokers
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1) To evaluate the efficacy of non surgical periodontal therapy(scaling and root planing) and surgical therapy on clinical parameters,blood pressure,serum crp and lipid profile in hypertensive patients with stageIII periodontitis.
2) 3) To compare the effect of surgical and non surgical periodontal treatment on clinical parameters,blood pressure,serum crp and lipid profile in hypertensive patients with Stage III periodontitis.  
assessed at baseline,2 weeks and 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
1) To evaluate the efficacy of non surgical periodontal therapy(scaling and root planing) on clinical parameters,blood pressure,serum crp and lipid profile in hypertensive patients with stageIII periodontitis.
2) To evaluate the efficacy of surgical therapy on clinical parameters,blood pressure,serum crp and lipid profile in hypertensive patients with Stage III periodontitis.
3) To compare the effect of surgical and non surgical periodontal treatment on clinical parameters,blood pressure,serum crp and lipid profile in hypertensive patients with Stage III periodontitis.
 
At the baseline a detailed case history, clinical parameters which includes plaque index (PI), Gingival Index (GI), Bleeding on probing (BOP), clinical attachment loss (CAL) and Probing pocket depth (PPD) will be recorded and blood samples will be collected for detection of c reactive protein levels and lipid profile and blood pressure to be recorded.The same is followed at 2 weeks after SRP and 3 months after flap surgery 
 
Target Sample Size   Total Sample Size="35"
Sample Size from India="35" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/08/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This clinico-hematological study will be conducted among patients aged over 18 years with known hypertension and Stage III periodontitis.The primary objective is to evaluate and compare the effectiveness of non-surgical periodontal therapy (scaling and root planing) and surgical periodontal therapy (flap surgery) on clinical periodontal parameters, blood pressure, serum C-reactive protein (CRP), and lipid profile in hypertensive patients with Stage III periodontitis.Eligible participants will undergo baseline assessment, including plaque index, gingival index, bleeding on probing, probing pocket depth, clinical attachment level, blood pressure measurement, and blood investigations for CRP and lipid profile. All patients will initially receive scaling and root planing. After 2 weeks, clinical and biochemical parameters will be reassessed. Patients with persistent periodontal pockets will then undergo flap surgery and will be re-evaluated at 3 months.The study aims to determine whether surgical therapy provides additional systemic and periodontal benefits compared to non-surgical treatment and to analyze changes in inflammatory markers and cardiovascular risk indicators over time.

 
Close